Signals from JPM Week for 2024 Business Development Planning

video-tile_Signals from JPM Week for 2024 Business Development Planning
Signals from JPM Week for 2024 Business Development Planning
January 18, 2024

Announcements around and during JPM Week each January often create waves throughout the biotechnology ecosystem. View this Biotechnology Innovation Organization (BIO) webinar to learn what experienced dealmakers and market analysts found most relevant and influential from JPM Week to consider when planning your own capital formation and partnering priorities for 2024. The discussion covers developments affecting M&A trends, the IPO window, licensing trends, biotech AI, and investor sentiment.

This webinar will also preview the program for the BIO CEO & Investor Conference, February 26-27, and explain how BIO’s One-on-One Partnering during the event can help you make progress against your 2024 priorities.

2024 BIO CEO Event and Partnering Overview
Moderators & Speakers
Donna LaVoie headshot
Donna LaVoie, Moderator
President and CEO
LaVoieHealthScience
Darren Ji headshot
Darren Ji, MD, PhD
Co-Founder, Chairman, Chief Executive Officer
Elpiscience
Sophie Jones MD headshot
Sophie Jones, MD
Managing Director, Healthcare Investment Banking
J.P. Morgan
Evan Loh headshot
Evan Loh, MD
CEO
Paratek Pharmaceuticals
Tim Opler
Tim Opler, PhD
Managing Director, Global Healthcare Group
Stifel